These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 9828234

  • 1. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes.
    Frangeul L, Cresta P, Perrin M, Lunel F, Opolon P, Agut H, Huraux JM.
    Hepatology; 1998 Dec; 28(6):1674-9. PubMed ID: 9828234
    [Abstract] [Full Text] [Related]

  • 2. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S, Lee JH, Roth WK.
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T, Enomoto N, Marumo F, Sato C.
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [Abstract] [Full Text] [Related]

  • 9. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C.
    Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
    [Abstract] [Full Text] [Related]

  • 10. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
    Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C.
    N Engl J Med; 1996 Jan 11; 334(2):77-81. PubMed ID: 8531962
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus and the controversial role of the interferon sensitivity determining region in the response to interferon treatment.
    Torres-Puente M, Cuevas JM, Jiménez-Hernández N, Bracho MA, García-Robles I, Carnicer F, del Olmo J, Ortega E, Moya A, González-Candelas F.
    J Med Virol; 2008 Feb 11; 80(2):247-53. PubMed ID: 18098147
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences.
    Pascu M, Martus P, Höhne M, Wiedenmann B, Hopf U, Schreier E, Berg T.
    Gut; 2004 Sep 11; 53(9):1345-51. PubMed ID: 15306598
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
    Yamamoto C, Enomoto N, Kurosaki M, Yu SH, Tazawa J, Izumi N, Marumo F, Sato C.
    Hepatology; 1997 Dec 11; 26(6):1616-20. PubMed ID: 9398006
    [Abstract] [Full Text] [Related]

  • 19. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
    Katano Y, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Goto H.
    Hepatogastroenterology; 2007 Dec 11; 54(75):854-7. PubMed ID: 17591078
    [Abstract] [Full Text] [Related]

  • 20. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.
    Nousbaum J, Polyak SJ, Ray SC, Sullivan DG, Larson AM, Carithers RL, Gretch DR.
    J Virol; 2000 Oct 11; 74(19):9028-38. PubMed ID: 10982347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.